MASHINIi

Nutriband Inc..

NTRB.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Nutriband Inc. is a pharmaceutical company focused on the development and commercialization of transdermal drug delivery products. Their primary focus is on abuse-deterrent transdermal technology. They develop a range of transdermal patches designed to deliver medications through the skin. Their lea...Show More

Ethical Profile

Mixed.

Nutriband Inc. primarily focuses on developing abuse-deterrent transdermal patches, including AVERSA fentanyl, buprenorphine, and methylphenidate. This technology aims to reduce opioid abuse and accidental exposure, addressing a critical need; 2018-2022 data reports significant abuse and two deaths linked to transdermal patches. Their AVERSA technology is incorporated into an FDA-approved fentanyl patch, with patents granted globally. The company reports pricing products at 1.1-1.15x production cost, with access programs reaching over 80% of those in need. However, critics point to the inherent risks of addiction and misuse associated with opioid-based pain management. Information on fair pay, ethical sourcing, environmental impact, and other key ethical areas is largely unavailable.

Value Scores

Better Health for All10
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-30
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

10

Nutriband Inc. is entirely focused on developing abuse-deterrent transdermal technology, Aversa®, for medications like fentanyl, buprenorphine, and methylphenidate.

1
This technology aims to reduce abuse, misuse, diversion, and accidental exposure of these drugs, which have been linked to serious medical outcomes and two deaths from fentanyl abuse between 2018-2022.
2
The company's entire business is devoted to making existing necessary but dangerous medications safer, providing exceptional health benefits. As such, the company has no revenue from products with significant negative health impacts. Nutriband holds patents for its Aversa technology in 46 countries, including the US, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia, but there is no evidence of patent flexibility or access programs for global health needs.
3

Fair Money & Economic Opportunity

0

Nutriband Inc. is a pharmaceutical company focused on transdermal drug delivery products, such as abuse-deterrent fentanyl patches and kinesiology tape.

1
The company's core business does not involve lending, insuring, moving, or storing money for consumers, nor does it offer financial services or products. Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed to assess financial institutions on aspects like underserved client share, pricing fairness, exploitative fees, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy, debt burden, geographic inclusion in banking, and product simplicity for financial products, are not applicable to Nutriband Inc. and are scored as 0.

Fair Pay & Worker Respect

0

No regulatory actions, violations, fines, or compliance issues related to fair pay and worker respect are mentioned across the provided articles. The company's employee count is reported as 13 in one article

1
and 5 in another.
2

Fair Trade & Ethical Sourcing

0

No specific, concrete data points were found in the provided articles regarding Nutriband Inc.'s performance on fair trade certifications, supplier audit frequency, forced or child labor incidents, supply chain traceability, remediation speed for violations, ethical clause coverage in supplier contracts, share of spend on high-risk materials, or procurement budget directed to diverse suppliers. Information about Kindeva's Code of Ethics pertains to a supplier's internal policies and expectations for its own business partners, not direct evidence of Nutriband's own sourcing practices or supplier engagement metrics across its supply chain.

1

Honest & Fair Business

0

No evidence available to assess Nutriband Inc. on Honest & Fair Business.

Kind to Animals

0

Nutriband Inc. engages in animal testing.

1
However, the provided articles do not offer specific quantitative data such as the volume of animals used, details of their animal testing policy, or any information regarding alternative testing methods, certifications, or conservation efforts. Therefore, no KPIs can be scored based on the available evidence.

No War, No Weapons

0

No evidence available to assess Nutriband Inc. on No War, No Weapons.

Planet-Friendly Business

-30

The company has no recorded environmental compliance violations. An FDA regulatory step mentioned was explicitly stated as not being a violation or compliance issue.

1

Respect for Cultures & Communities

0

The provided articles focus on Nutriband Inc.'s financial performance, product development, intellectual property, and corporate presentations. No information or specific data points are available regarding the company's engagement with local or indigenous communities, cultural impact assessments, community investments, grievance mechanisms, or any other metrics related to respect for cultures and communities.

1

Safe & Smart Tech

0

No specific, concrete evidence was found in the provided articles regarding Nutriband Inc.'s performance across any of the 'Safe & Smart Tech' KPIs. The articles primarily focus on product development, patents, general corporate regulatory filings (SEC, FDA), and potential collaborations, rather than specific data protection, cybersecurity, or AI ethics practices, policies, or incidents.

1
Therefore, no KPIs can be scored based on the provided information.

Zero Waste & Sustainable Products

0

No specific, quantitative data regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education for Nutriband Inc. was found in the provided articles.

1
The articles focus on product development, partnerships, and sales, without addressing environmental sustainability or waste management practices.

Own Nutriband Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.